By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > Synopsys stock rises as chip-design company’s earnings, outlook top Street view
Investing

Synopsys stock rises as chip-design company’s earnings, outlook top Street view

News Room
Last updated: 2023/08/17 at 12:49 PM
By News Room
Share
3 Min Read
SHARE

Synopsys Inc. shares rose in the extended session Wednesday after the chip-design verification and automation company topped Wall Street earnings expectations and named a new chief executive.

Synopsys
SNPS,
+0.28%
shares rose about 2% after hours, following a 2% decline in the regular session to close at $428.21. At Wednesday’s close, shares are up 34% year to date, compared with a 15% gain by the S&P 500 index
SPX.

Along with results, the company announced that Sassine Ghazi, the current president and chief operating officer, will succeed Chairman Aart de Geus as chief executive on Jan. 1, 2024.

The company reported third-quarter net income of $336.3 million, or $2.17 a share, compared with $222.6 million, or $1.43 a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation expenses and other items, were $2.88 a share, compared with $2.10 a share in the year-ago period.

Revenue rose to $1.49 billion from $1.25 billion in the year-ago quarter.

Analysts surveyed by FactSet had forecast $2.74 a share on revenue of $1.48 billion.

Synopsys forecast earnings of $3.01 to $3.06 a share on revenue of $1.56 billion to $1.6 billion for the fourth quarter, and $11.04 to $11.09 a share on revenue of $5.81 billion to $5.84 billion for the year.

Analysts had estimated earnings of $2.91 a share on revenue of $1.57 billion for the fiscal fourth quarter, and $10.82 a share on revenue of $5.82 billion for the year.

Back in March, Synopsys launched its suite of AI-driven chip-design verification, testing and manufacturing tools, Synopsis.ai.

Also in March, Nvidia Corp.
NVDA,
+0.40%
said that third-party foundry Taiwan Semiconductor Manufacturing Co. 
TSM,
+0.60%
and Synopsys will be using its cuLitho software library that improves upon computational lithography, a process that allows for better resolution of etched transistors as they get smaller.

On Monday, Synopsis announced a broader IP and electronic design automation partnership with Intel Corp.
INTC,
-1.92%
On Wednesday, Intel announced it was no longer acquiring Tower Semiconductor Ltd.
TSEM,
+2.09%
because it did not receive regulatory approvals for the deal on time.

Read the full article here

News Room August 17, 2023 August 17, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why Trump Is Targeting Federal Reserve Chair Jerome Powell

Watch full video on YouTube

Trump to offer some tariff exemptions as the cost of groceries climbs

Watch full video on YouTube

Wall Street hits back at Trump’s plan to limit interest on credit cards

Major US banks have lashed out at Donald Trump’s proposal to cap…

Franklin Moderate Allocation Fund Q3 2025 Commentary

Franklin Resources, Inc. is a global investment management organization with subsidiaries operating…

Forget Injections. Now You Can Just Take Pills For Weight Loss

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?